Search results
FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma
Benzinga via Yahoo Finance· 1 year agoThe FDA has approved Roche Group AG's (OTC: RHHBY) Genentech's Polivy (polatuzumab vedotin-piiq) in...
Roche (RHHBY) Polivy Combination for DLBCL Gets Full Approval
Zacks via Yahoo Finance· 1 year agoRoche (RHHBY) gets full approval for Polivy (polatuzumab vedotin-piiq) in combination with Rituxan,...